Get started
Author

Erkan Y. Osman

Observed names: E Y Osman, E. Y. Osman, E.Y. Osman, EY Osman, Erkan Osman, Erkan Y Osman, Osman, Erkan Y.
Observed institution: University of Missouri
ORCID: 0000-0002-8887-8728
Observed ORCID: 0000-0002-8887-8728
OpenAlex ID: A5080172098
Delivery of Therapeutic Agents Through Intracerebroventricular (ICV) and Intravenous (IV) Injection in Mice
2011 · Jacqueline J. Glascock, Erkan Y. Osman, et al. · Journal of Visualized Experiments · 121
PDF
Delivery of bifunctional RNAs that target an intronic repressor and increase SMN levels in an animal model of spinal muscular atrophy
2009 · T. D. Baughan, A. Dickson, et al. · Human Molecular Genetics · 115
PDF
Bifunctional RNAs Targeting the Intronic Splicing Silencer N1 Increase SMN Levels and Reduce Disease Severity in an Animal Model of Spinal Muscular Atrophy
2011 · Erkan Y Osman, Pei-Fen Yen, et al. · Molecular Therapy · 66
Plastin-3 extends survival and reduces severity in mouse models of spinal muscular atrophy
2017 · Kevin A. Kaifer, Eric Villalón, et al. · JCI Insight · 65
PDF
A Negatively Acting Bifunctional RNA Increases Survival Motor Neuron Both In Vitro and In Vivo
2008 · Alexa Dickson, Erkan Osman, et al. · Human Gene Therapy · 64
Defining the therapeutic window in a severe animal model of spinal muscular atrophy
2014 · K. L. Robbins, J. J. Glascock, et al. · Human Molecular Genetics · 63
PDF
Morpholino antisense oligonucleotides targeting intronic repressor Element1 improve phenotype in SMA mouse models
2014 · Erkan Y. Osman, Madeline R. Miller, et al. · Human Molecular Genetics · 62
PDF
Decreasing Disease Severity in Symptomatic, Smn −/− ; SMN2 +/+ , Spinal Muscular Atrophy Mice Following scAAV9-SMN Delivery
2011 · Jacqueline J. Glascock, Erkan Y. Osman, et al. · Human Gene Therapy · 52
Enhancement of SMN protein levels in a mouse model of spinal muscular atrophy using novel drug‐like compounds
2013 · Jonathan J. Cherry, Erkan Y. Osman, et al. · EMBO Molecular Medicine · 48
PDF
Comparison of independent screens on differentially vulnerable motor neurons reveals alpha-synuclein as a common modifier in motor neuron diseases
2017 · Rachel A. Kline, Kevin A. Kaifer, et al. · PLoS Genetics · 45
PDF
Rescue of a Mouse Model of Spinal Muscular Atrophy With Respiratory Distress Type 1 by AAV9-IGHMBP2 Is Dose Dependent
2016 · Monir Shababi, Zhihua Feng, et al. · Molecular Therapy · 42
PDF
Development and characterization of an SMN2-based intermediate mouse model of Spinal Muscular Atrophy
2013 · Melissa S. Cobb, Ferril F. Rose, et al. · Human Molecular Genetics · 36
Optimization of Morpholino Antisense Oligonucleotides Targeting the Intronic Repressor Element1 in Spinal Muscular Atrophy
2016 · Erkan Y Osman, Charles W Washington, et al. · Molecular Therapy · 30
PDF
AAV9-Stathmin1 gene delivery improves disease phenotype in an intermediate mouse model of spinal muscular atrophy
2019 · E Villalón, R A Kline, et al. · Human Molecular Genetics · 29
Delivery of Therapeutic Agents Through Intracerebroventricular (ICV) and Intravenous (IV) Injection in Mice
2011 · Jacqueline J. Glascock, Erkan Y. Osman, et al. · Journal of Visualized Experiments · 28
Minor snRNA gene delivery improves the loss of proprioceptive synapses on SMA motor neurons
2020 · Erkan Y. Osman, Meaghan Van Alstyne, et al. · JCI Insight · 23
PDF
Motor unit recovery following Smn restoration in mouse models of spinal muscular atrophy
2022 · Laura H Comley, Rachel A Kline, et al. · Human Molecular Genetics · 20
PDF
Analysis of Azithromycin Monohydrate as a Single or a Combinatorial Therapy in a Mouse Model of Severe Spinal Muscular Atrophy
2017 · Erkan Y. Osman, Charles W. Washington, et al. · Journal of Neuromuscular Diseases · 19
A Negatively-Acting Bifunctional RNA Increases Survival Motor Neuron in vitro and in vivo
2008 · Alexa Dickson, Erkan Osman, et al. · Human Gene Therapy · 18
Functional characterization of SMN evolution in mouse models of SMA
2019 · Erkan Y. Osman, Madeline R. Bolding, et al. · Scientific Reports · 13
PDF
Intraperitoneal delivery of a novel drug‐like compound improves disease severity in severe and intermediate mouse models of Spinal Muscular Atrophy
2019 · E. Y. Osman, A. Rietz, et al. · Scientific Reports · 9
PDF
Short-duration splice promoting compound enables a tunable mouse model of spinal muscular atrophy
2020 · A Rietz, KJ Hodgetts, et al. · Life Science Alliance · 2
PDF
Placental development in a mouse model of spinal muscular atrophy
2015 · Gerialisa Van Gronigen Caesar, Jeffrey M. Dale, et al. · Biochemical and Biophysical Research Communications · 2
Gene Therapy for Spinal Muscular Atrophy
2017 · M.R. Miller, E.Y. Osman, et al. · Elsevier eBooks · 1
Gene Therapy in Spinal Muscular Atrophy (SMA) Models Using Intracerebroventricular Injection into Neonatal Mice
2015 · Monir Shababi, Erkan Y. Osman, et al. · Neuromethods
Works count: 27
Citation count: 973
H-index: 18
I10-index: 20
Year
Topic
Type